Subscribe to the print version of CBNW quarterly and monthly latest newsletter and never miss the latest CBRNe and EOD news!
Our newsletter is sent once a month, and you will receive CBNW Magazine each quarter.
Emergent BioSolutions Inc. is carrying out the Phase 3 clinical trial that is evaluating plasma-derived therapy COVID-HIG as a potential treatment for hospitalized patients...
By Sgt. Calvin Deinum, Platoon Sergeant of the multifunctional CBRN platoon of the 11th Armored Engineer Battalion form Wezep, The Netherlands
Introduction
My name is Calvin...
Can you introduce yourself and your company?
George: My name is George J. Mckerrow and I am the Director of International Sales & Training Coordinator...
By PhD. Greg Simons, Associate Professor, University of Uppsala, Sweden
Preparing for future crisis events through scenarios and training, including the practice in role play...
By Mr. Donald E. Parman, Office of R&D Director, Integration Division, International Innovation and Interagency Programs
INTRODUCTION Throughout the long history of warfare and regardless...
A CCDC Chemical Biological Center team of specialists customized, transported, and operated a mobile laboratory to test more than 3,000 Soldiers for COVID-19 at...
By BG (Ret.) William King, Former Commander, 20th CBRNE Command, U.S. Army, USA
During the next five years, we will face complex challenges, including coordinating...
By Prof. Natividad Carpintero-Santamaría, General Secretary of the Instituto de Fusión Nuclear “Guillermo Velarde”, Spain.
The 21st century is characterized by a complex international scenario...
As employees continue returning to the office, travelers start flying again, and fans slowly return to stadiums, technology that focuses on maintaining health and...
Agilent Technologies Inc. announced that the Agilent Vaya Raman raw material identity verification system has received a 2020 R&D 100 Award in the Analytical/Test...